key: cord-0312318-ajxyr8tb
authors: Oja, Anna E.; Morgana, Florencia; Hagen, Ruth; Ghandour, Cherien A.; Nolte, Martijn A.; Rooijakkers, Suzan H.M.; van Lier, René A.W.; Bardoel, Bart W.; Hombrink, Pleun
title: Polyfunctional pathogen-specific CD4+ T cells reside in the lungs and tumors of NSCLC patients
date: 2022-02-19
journal: bioRxiv
DOI: 10.1101/2022.02.16.479923
sha: 1750084e469c3dab057e78c31805fd9de444d21f
doc_id: 312318
cord_uid: ajxyr8tb

Local T cell responses are required for optimal protection of the lungs against airborne pathogens. This localized protection is mediated by various immune cells, including resident memory T cells (TRM). While human lung CD8+ TRM line the epithelium and are enriched for recognition of respiratory viruses, we found CD4+ TRM to exhibit more heterogeneous localization patterns, surrounding airways, forming clusters in the lung parenchyma, and lining the epithelium. This heterogeneity was also reflected functionally, as lung CD4+ TRM were enriched for recognition of diverse classes of respiratory pathogens. Upon stimulation, lung CD4+ TRM expressed different polyfunctional cytokine profiles depending on the pathogen recognized. CD4+ TRM responding to respiratory viruses and bacteria were biased for production of IFN-γ and IL-17, respectively. Strikingly, pathogen-specific CD4+ TRM also represent a significant fraction in NSCLC tumors that remained polyfunctional despite high PD-1 expression. These findings are not only important for vaccine design, but also provide a rationale for reinvigorating anti-tumor immunity through triggering of polyfunctional pathogen-specific CD4+ tumor infiltrating lymphocytes.

Long-term memory T cells remain after the clearance of a pathogen and are designed to 48 prevent secondary infections. Deposition of T cells at former sites of pathogen entry is pivotal to 49 this task. These cells are known as resident memory T cells (TRM), as they reside within tissues, 50 in disequilibrium to the circulation, to mediate localized protection 3 . CD8 + TRM inhabit various 51 tissues, including the lungs, and their protective roles against secondary lung infections are 52 evident 4,5 . In mice, lung CD8 + TRM create niches around sites of regeneration following tissue 53 damage 6 . Human CD103 + CD8 + TRM line the lung epithelium and are programmed for tissue 54 surveillance 7,8 . Furthermore, CD103 + CD8 + TRM are enriched for recognition of localized viruses, 55 influenza and RSV, but not systemic viruses, CMV or EBV 7 . The localization of CD8 + TRM is key 56 for rapid responses to secondary pathogen encounter. 57 enriched in the CD103 + TRM population 7 , very few CD4 + T cells specific for respiratory 137 pathogens expressed CD103 in the lung. Approximately 20% of A. fumigatus-specific lung CD4 + 138 T cells expressed both CD69 and CD103, but the majority were still CD103 -CD69 + . On the other 139 hand, S. aureus-specific CD4 + T cells appeared to express less CD69 than other pathogen-140 specific cells. However, the phenotypes were not enriched compared to total non-naïve lung 141

CD4 + T cells (Supplementary figure 3C) . To investigate the activation status of the pathogen-142 specific CD4 + TRM, we determined the expression of PD-1 and CD39 on CMV-, influenza-, and 143

A. fumigatus-specific CD4 + T cells. The expression of these two molecules is not altered by the 144 stimulation, because the addition of Brefeldin A to the assay blocks the upregulation of surface 145 proteins 25 (Supplementary figure 2D) . Therefore, we could assess which cells already 146 expressed PD-1 and CD39 prior to the stimulation. Interestingly, the majority of the pathogen-147 specific CD4 + T cells expressed PD-1, but not CD39 ( Figure 2F, Supplementary figure 2E) . 148 PD-1 is also a part of the TRM core signature 8,10,11 . Therefore, the expression of CD69 and PD-1 149 and the lack of CD39 on the pathogen-specific CD4 + T cells strongly suggests that these cells 150 are resident and not chronically activated or blood contaminants. Furthermore, the lack of 151 CD103 expression indicates localization within clusters in the parenchyma rather than 152 distribution along the lung epithelium. pathogen recognition 155 To investigate whether CD4 + TRM also skew towards distinct Th1 or Th17 cytokine profiles, we 156 examined the combined upregulation of CD40L and IFN-γ, IL-17a, and TNF-α production of 157 lung CD4 + TRM after overnight stimulation with polyclonal αCD3 mAb. In comparison to antigen-158 experienced CD4 + T cells in paired blood, antigen-experienced CD4 + T cells in the lungs 159 produced significantly more IFN-γ, but similar amounts of IL-17a (Supplementary figure 3A) . 160

Lung CD4 + T cells produced IFN-γ and IL-17a, but these cytokines were not co-produced 161 ( Figure 3A) . Furthermore, there were significantly more IFN-γ-producing Th1-type CD4 + T cells 162 than IL-17a-producing Th17-type cells ( Figure 3B ). To ascertain whether these Th1 and Th17 163 cells exhibited a TRM phenotype, the expression of CD69 and CD103 was measured on the 164 cytokine-producing cells. The IL-17-producing cells were enriched for a CD69 + CD103 -TRM 165 phenotype compared to both the total and IFN-γ-producing CD4 + T cells. Interestingly, contrary 166 to CMV-, influenza-, and RSV-specific CD4 + T cells that were enriched for a CD69 + CD103 -TRM 167 phenotype, the total IFN-γ producing CD4 + T cells skewed towards CD69 -CD103phenotype 168 ( Figure 3C-G) . This phenotypic enrichment was not observed for TNF-α producing cells, a 169 cytokine not distinguishing specific helper types (Supplementary figure 3B) . At the pathogen-170 specific level, the virus-specific CD4 + TRM skewed towards IFN-γ production and were the most 171 polyfunctional pathogen-specific CD4 + T cells, producing IFN-γ, TNF-α, and IL-2. A. fumigatus-172 specific CD4 + TRM also produced more IFN-γ than IL-17a. A subset of CMV-specific lung CD4 + T 173 cells produced IL-17a rather than IFN-γ. CD4 + T cells recognizing S. aureus and S. pneumoniae 174 mainly produced IL-17a (Figure 3H,I) . Altogether, these data demonstrate that the human lung 175 contains both type 1 and 17 CD4 + T cells with distinct cytokine and phenotypic profiles allowing 176 them to contribute to the adaptive immune response against a wide range of pathogens. 177 assay described above. Intriguingly, all tumor samples tested contained CD4 + T cells specific for 183 the analyzed pathogens. Influenza-, RSV-, and A. fumigatus-specific CD4 + T cells were even 184 enriched in the tumors compared to paired blood and comparable to frequencies detected in the 185 lungs ( Figure 4A,B) . Responses against S. pneumoniae were not tested due to limited number 186 of cells obtained from tumor samples. For the majority of samples and pathogens, presence of 187 pathogen-specific CD4 + T cells in peripheral blood was predictive for these cells in the tumor. A 188 large portion of the pathogen-specific, as well as total non-naïve, CD4 + TILs exhibited a 189 residency phenotype, demonstrated by the expression of CD69 or CD69 and CD103, 190 suggesting that these cells are not blood contaminants but reside in the tumors (Figure 5A ,B, 191

A major obstacle in anti-cancer immunity is the immunosuppressive tumor microenvironment 193 (TME). Expression of inhibitory receptors, including PD-1, are often used to identify chronically 194 stimulated T cells that lost the capacity to become activated and are therefore referred to as 195 "exhausted". To investigate whether PD-1 expression is altered on pathogen-specific CD4 + 196

TILs, we compared PD-1 expression on pathogen-specific CD4 + T cells in paired lung and 197 tumor samples. The majority of pathogen-specific CD4 + T cells expressed PD-1 regardless of 198 the tissue (Supplementary figure 2G) . However, the expression level of PD-1 was significantly 199 higher on pathogen-specific CD4 + T cells in the tumor than in the paired lung samples, which 200

indicates dysfunctionality (Figure 5C,D) . Therefore, the cytokine profiles of the pathogen-201 specific CD4 + TILs was assessed. Intriguingly, the pathogen-specific CD4 + TILs displayed 202 comparable polyfunctionality and pathogen-specific cytokine profiles as observed in the healthy 203 lungs (Figure 5E,F) . These data show that pathogen-specific CD4 + TILs in NSCLC resist 204 exhaustion, and are licensed to respond with distinct effector functions, which may be 205 therapeutically exploited for anti-tumor immunity. 206

Lung CD4 + TRM serve an important role in the local immune response to airway pathogens. 208

Localization is key to the functionality of TRM, as they strategically line the sites of pathogen 209 entry, poised to trigger the alarm and curb the onset of infection. While transcriptional and 210 phenotypic heterogeneity among CD4 + TRM is well appreciated, the functional consequences, 211 spatial organization and purpose of the different subsets remain unknown. Here, we 212 demonstrate that in contrast to human lung CD8 + TRM that line the airway epithelium, lung CD4 + 213 TRM also reside in the parenchyma surrounding airways and reside in clusters with other cells. 214

While lung CD8 + TRM are primarily involved in protection against respiratory viruses, CD4 + TRM 215 recognized a wide range of airway pathogens, including viruses, bacteria, and fungi. As such, 216

it's conceivable that CD4 + TRM may also play a role in mediating the intricate balance between 217 the lung microbiome and immune system. As different pathogens exploit different routes of 218 entry, presumably the various pathogen-specific CD4 + TRM reside in different niches requiring 219 different phenotypic characteristics. Total IFN-γ producing lung CD4 + T cells skewed towards a 220 CD69non-TRM phenotype, compared to IL-17a producing CD4 + T cells enriched in the CD69 + 221 TRM population. We also showed that CD69 + CD4 + TRM and CD69 -CD4 + T cells form separate 222 clusters within the lung parenchyma. This suggests differential clustering of Th1 and Th17 type 223 CD4 + T cells in the parenchyma, presumably recognizing intracellular versus extracellular 224 pathogens, respectively. However, the majority of CD4 + T cells specific for pathogens tested 225

here, including viruses, expressed CD69. Perhaps the CD69 -CD4 + T cells recognize pathogens 226 enter circulation and thereby escape the lung T cell repertoire. 228

The lifespan of TRM, especially in humans, is still not fully understood. In mice, CD8 + TRM in the 229 lungs diminish over time in the absence of antigen, whereas CD8 + TRM persist in other tissues, 230 such as the skin and gut 26-28 . Antigen persistence is required for prolonged replenishment and Pathogen-specific bystander CD4 + T cells with a residency phenotype also reside in tumors of 248 NSCLC patients. In the last years, it has become evident that a large proportion of CD8 + and 249 CD4 + TILs are not tumor-specific 21,37 . Furthermore, many patients fail to respond to immune 250 checkpoint therapy or adoptive cell transfer regimens. Recently, an alternative approach was 251

proposed. The use of anti-viral peptide therapy to trigger virus-specific bystander CD8 + TILs 252 within tumors to activate surrounding innate and adaptive immune cells and recruit more 253 immune cells to the tumor 23 . Thereby, transforming "cold" tumors into "hot" tumors. Viral-specific 254 bystander CD4 + and CD8 + TILs produce cytokines, such as IFN-γ. While IFN-γ secreted by 255 tumor-specific T cells exhibits direct cytopathic and cytostatic effects on tumor cells, IFN-γ can 256 also diffuse throughout the tumor and indirectly alter tumor cells not recognized by T cells 38, 39 . 257

The generated cytokine field upregulates MHC class I expression on tumor cells making them 258 more susceptible to tumor-specific CD8 + T cells. However, tumor cells also upregulate PD-L1 259 potentially increasing tumor immunosuppression. Instead of IFN-γ, fungiand bacteria-specific 260 CD4 + TILs produced IL-17a, which promotes tumor growth in several cancers, including lung 261 cancer 40 . Here, we show that pathogen-specific bystander CD4 + TILs produce IFN-γ or IL-17a 262 depending on the pathogen recognized. Therefore, while the use of pathogen-specific CD4 + T 263 cells may add to this alternative approach, their potential anti-versus pro-tumor roles, especially 264 in regard to IL-17a producing bystander CD4 + TILs, need careful assessment. 265

The major hurdle for current cancer immunotherapies is the immunosuppressive TME and 266 resulting loss of T cell functionality. Here, we show that pathogen-specific CD4 + T cells in the 267 tumor expressed higher levels of PD-1 than pathogen-specific CD4 + T cells in paired lung 268 tissue, indicative of direct or indirect activation in the TME and consequently, dysfunctionality. 269

On the contrary, pathogen-specific CD4 + TILs retained their polyfunctionality, suggesting that and ImageJ were used for imaging and analysis respectively. 307 

Lung Homeostasis : Influence of Age, Microbes, and the Immune 12

Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal 13

IL-15 supports the generation of protective lung-resident memory CD4 T cells

Regionally compartmentalized resident memory T cells mediate naturally 397 acquired protection against pneumococcal pneumonia

Antigen discovery unveils resident memory and migratory cell roles in 399 antifungal resistance

CD103hi Treg cells constrain lung fibrosis induced by CD103lo tissue-resident 401 pathogenic CD4 T cells

Oncology Meets Immunology: The Cancer-Immunity Cycle

Tissue-resident memory features are linked to the magnitude of cytotoxic T 406 cell responses in human lung cancer

CD4+ T cell help in cancer 408 immunology and immunotherapy

Low and variable tumor reactivity of the intratumoral TCR repertoire in human 34

Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness

Tissue-resident memory Th17 cells maintain stable 441 fungal commensalism in the oral mucosa

Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal 444

Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation. 445 Gastroenterology

Polyfunctional tumor-reactive T cells are effectively expanded from non-small 447 cell lung cancers , and correlate with an immune-engaged T cell profile

Bystander IFN-γ activity promotes widespread and sustained cytokine signaling 450 altering the tumor microenvironment

Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted 452 IFN-γ

Targeting the Tumor Microenvironment : The Protumor Effects of IL-17 Related to 454 Cancer Type

Boosting the MHC Class II-Restricted Tumor Antigen Presentation to CD4+ T 456

Helper Cells: A Critical Issue for Triggering Protective Immunity and Re-Orienting the Tumor 457

Microenvironment Toward an Anti-Tumor State

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect

The authors declare no competing interests. 495